| Funding Life Sciences: Where to Now? SDVG. The environment for traditional means of funding private companies in the life science industry has changed forever. No longer are venture capitalists the logical choice for funding companies with pre-clinical programs. By the same token, using vast amounts of cash to advance these programs is no longer condoned.Join us on Thursday, February 25 as our panel of experienced investors explores how companies in the life science industry can seek to accomplish their goals with -- or without -- traditional funding from venture capitalists. See http://www.sdvg.org |
RSS